Beta Bionics Chief Commercial Officer Mark Hopman sells common shares worth $13,446.25
BBNX•Chief Commercial Officer Mark Hopman sold 775 Beta Bionics common shares at $17.35 each on October 14, 2026, leaving him with 55,334 shares.
1. Share sale
Mark Hopman sold 775 common shares at $17.35 per share on October 14, 2026. His direct holdings stood at 55,334 common shares after the transaction.
